REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,209 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,066 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,906,259 shares of 104,986,330 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include FMR LLC (10,809,746 shares), BlackRock Inc. (9,487,243 shares), VANGUARD GROUP INC (8,648,125 shares), Capital World Investors (6,225,599 shares), JPMORGAN CHASE & CO (5,705,869 shares), STATE STREET CORP (5,051,759 shares), WELLINGTON MANAGEMENT GROUP LLP (2,443,289 shares), Dodge & Cox (2,286,509 shares), GEODE CAPITAL MANAGEMENT, LLC (2,240,113 shares), and Capital International Investors (1,767,136 shares).
This table shows the top 1,066 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.